跳至主要内容
临床试验/NCT07103629
NCT07103629已完成不适用

Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected

AstraZeneca1 个研究点 分布在 1 个国家目标入组 8,428 人开始时间: 2025年5月31日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
8,428
试验地点
1
主要终点
CKD potential prevalence

研究概览

简要总结

This is a multicenter cross-sectional study will randomly screen kidney function in adult patients with known risk factors for chronic kidney disease (CKD) within the Brazilian general population. Kidney function will be assessed using a point-of-care creatinine test at local healthcare facilities. Patients with abnormal test results will be referred for laboratory confirmation within three months and will undergo evaluation by the local nephrology team to determine the need for follow-up care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • At least one risk factor for CKD as mentioned above.

排除标准

  • Patients with previous diagnosis of CKD
  • Patients younger than 18 years old
  • Patients unable to give informed consent to participate in the study.

结局指标

主要结局

CKD potential prevalence

时间窗: Through study completation, an avarege 1 year

To estimate the prevalence of Chronic Kidney Disease (CKD) in Brazil through random screening using a portable device for creatinine measurement and eGFR estimation in adult patients with risk factors for the development of CKD across the five regions of the country.

次要结局

  • Regional CKD potential prevalence(Through study completation, an avarege 1 year)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验